The Oncology Institute Inc
(TOI)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 49,669 | 33,488 | 14,010 | 115,174 | 5,998 |
| Marketable Securities | 0 | 49,367 | 59,796 | N/A | N/A |
| Receivables | 48,681 | 42,911 | 40,433 | 21,244 | 17,259 |
| Inventories | 10,039 | 13,678 | 9,261 | 6,438 | 4,354 |
| TOTAL | $112,418 | $143,493 | $130,418 | $154,056 | $29,720 |
| Non-Current Assets | |||||
| PPE Net | 11,888 | 10,883 | 8,547 | 4,192 | 2,104 |
| Investments And Advances | 0 | 0 | 58,354 | 0 | 0 |
| Intangibles | 22,040 | 25,134 | 39,375 | 44,871 | 33,743 |
| Other Non-Current Assets | 26,371 | 29,730 | 24,971 | 320 | 122 |
| TOTAL | $60,299 | $65,747 | $131,247 | $49,383 | $35,969 |
| Total Assets | $172,717 | $209,240 | $261,665 | $203,439 | $65,689 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | N/A | 183 | 5,368 |
| Accounts payable and accrued liabilities | 24,324 | 14,429 | 9,372 | 15,559 | 12,643 |
| Accrued Expenses | 21,093 | 13,996 | 14,595 | 13,924 | 9,452 |
| TOTAL | $52,215 | $34,788 | $29,720 | $29,798 | $28,607 |
| Non-Current Liabilities | |||||
| Long Term Debt | 93,131 | 86,826 | 80,621 | N/A | 6,561 |
| Other Non-Current Liabilities | 23,750 | 30,569 | 28,041 | 69,111 | 807 |
| TOTAL | $116,913 | $117,427 | $108,770 | $69,482 | $8,981 |
| Total Liabilities | $169,128 | $152,215 | $138,490 | $99,280 | $37,588 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 75,753 | 74,313 | 74,552 | 73,249 | 28,750 |
| Common Shares | 8 | 8 | 7 | 7 | 6 |
| Retained earnings | -210,813 | -146,150 | -63,082 | -63,234 | -52,307 |
| Other shareholders' equity | -19 | -19 | 0 | 0 | 0 |
| TOTAL | $3,589 | $57,025 | $123,175 | $104,159 | $28,101 |
| Total Liabilities And Equity | $172,717 | $209,240 | $261,665 | $203,439 | $65,689 |